随着公司报告收入丰厚,生物生命解决方案执行官出售了大量股票。 BioLife Solutions executives sell significant stock portions as company reports strong earnings.

Sarah Aebersold和Todd Berard是生物生命解决方案公司的经理,他们最近出售了相当一部分公司股票。 Sarah Aebersold and Todd Berard, executives at BioLife Solutions, have recently sold significant portions of their company stock. Aebersold出售了5 771个股份,将她的股份减少了6.72%,Berard出售了8 902个股份,将他的拥有权减少了6.15%。 Aebersold sold 5,771 shares, reducing her holdings by 6.72%, while Berard sold 8,902 shares, decreasing his ownership by 6.15%. 生物生命解决方案开发了细胞和基因治疗工具,最近报告季度收入强劲,EPS为26美元,收入为2 271万美元,超过分析师的期望。 BioLife Solutions, which develops tools for cell and gene therapy, recently reported strong quarterly earnings, with EPS of $0.26 and revenue of $22.71 million, surpassing analyst expectations.